Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-005553
Filing Date
2019-05-09
Accepted
2019-05-09 16:02:36
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cdxc10q_mar312019.htm 10-Q 1250811
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 10576
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 11498
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 6439
  Complete submission text file 0001654954-19-005553.txt   3739813

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cdxc-20190331.xml EX-101.INS 601036
6 XBRL TAXONOMY EXTENSION SCHEMA cdxc-20190331.xsd EX-101.SCH 32493
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdxc-20190331_cal.xml EX-101.CAL 55936
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdxc-20190331_def.xml EX-101.DEF 66331
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdxc-20190331_lab.xml EX-101.LAB 239176
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdxc-20190331_pre.xml EX-101.PRE 189860
Mailing Address 10900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37752 | Film No.: 19810399
SIC: 2833 Medicinal Chemicals & Botanical Products